Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Operating Expenses | 17,455 | 16,759 | 17,310 | 10,773 | 10,442 |
| Operating Income | -17,455 | -16,759 | -17,310 | -10,773 | -17,436 |
| Interest Expense | 756 | 751 | 728 | 563 | 1,159 |
| Other Income | 2,931 | 3,333 | 3,075 | 595 | -77,459 |
| Pre-tax Income | -15,280 | -14,177 | -14,963 | -10,741 | -96,054 |
| Income Tax | 19 | -29 | 21 | -30 | N/A |
| Net Income Continuous | -15,299 | -14,148 | -14,984 | -10,711 | -82,497 |
| Net Income | $-15,299 | $-14,148 | $-14,984 | $-10,711 | $-82,497 |
| EPS Basic Total Ops | -0.30 | -0.32 | -0.38 | -0.46 | -150.98 |
| EPS Basic Continuous Ops | -0.30 | -0.32 | -0.38 | -0.46 | -118.45 |
| EPS Diluted Total Ops | -0.30 | -0.32 | -0.38 | -0.46 | -150.98 |
| EPS Diluted Continuous Ops | -0.30 | -0.32 | -0.38 | -0.46 | -118.45 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.32 | -0.38 | N/A | N/A |
| EBITDA(a) | $-17,604 | $-16,677 | $-17,232 | $-10,693 | $-10,393 |